Cargando…

Glycogen Synthase Kinase 3β Inhibition as a Therapeutic Approach in the Treatment of Endometrial Cancer

Alternative strategies beyond current chemotherapy and radiation therapy regimens are needed in the treatment of advanced stage and recurrent endometrial cancers. There is considerable promise for biologic agents targeting the extracellular signal-regulated kinase (ERK) pathway for treatment of thes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Yan, Kizer, Nora T., Thaker, Premal H., Chiappinelli, Katherine B., Trinkaus, Kathryn M., Goodfellow, Paul J., Ma, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759928/ https://www.ncbi.nlm.nih.gov/pubmed/23941783 http://dx.doi.org/10.3390/ijms140816617

Ejemplares similares

Glycogen synthase kinase 3β in tumorigenesis and oncotherapy
por: He, Rui, et al.
Publicado: (2020)

Glycogen synthase kinase 3β inhibition enhances Notch1 recycling
por: Zheng, Li, et al.
Publicado: (2018)

Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011)

Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
por: Domoto, Takahiro, et al.
Publicado: (2020)

The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker
por: Chen, Shuo, et al.
Publicado: (2016)

Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma
por: Abe, Kensaku, et al.
Publicado: (2019)

Inhibition of glycogen synthase kinase 3β prevents NSAID-induced acute kidney injury
por: Bao, Hao, et al.
Publicado: (2012)

Isoorientin Inhibits Inflammation in Macrophages and Endotoxemia Mice by Regulating Glycogen Synthase Kinase 3β
por: Li, Yingui, et al.
Publicado: (2020)

Association of glycogen synthase kinase-3β with Parkinson’s disease (Review)
por: LI, DA-WEI, et al.
Publicado: (2014)

Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer
por: Shimasaki, Takeo, et al.
Publicado: (2012)

Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD
por: Ngkelo, Anta, et al.
Publicado: (2015)

Glycogen synthase kinase 3β in Toll-like receptor signaling
por: Ko, Ryeojin, et al.
Publicado: (2016)

Amaryllidaceae Alkaloids as Potential Glycogen Synthase Kinase-3β Inhibitors
por: Hulcová, Daniela, et al.
Publicado: (2018)

Glycogen synthase kinase 3β suppresses polyglutamine aggregation by inhibiting Vaccinia-related kinase 2 activity
por: Lee, Eunju, et al.
Publicado: (2016)

Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma
por: Bolidong, Dilireba, et al.
Publicado: (2020)

Acute Glycogen Synthase Kinase-3 Inhibition Modulates Human Cardiac Conduction
por: Li, Gang, et al.
Publicado: (2022)

Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer
por: Chen, Shuo, et al.
Publicado: (2016)

Interactomes of Glycogen Synthase Kinase-3 Isoforms
por: Cormier, Kevin W., et al.
Publicado: (2023)

Lithium Enhances Axonal Regeneration in Peripheral Nerve by Inhibiting Glycogen Synthase Kinase 3β Activation
por: Su, Huanxing, et al.
Publicado: (2014)

Inhibition of Glycogen Synthase Kinase-3β Attenuates Glucocorticoid-Induced Suppression of Myogenic Differentiation In Vitro
por: Ma, Zhenyu, et al.
Publicado: (2014)

Glycogen Synthase Kinase-3β Inhibition with 9-ING-41 Attenuates the Progression of Pulmonary Fibrosis
por: Jeffers, Ann, et al.
Publicado: (2019)

Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy
por: Haq, Syed, et al.
Publicado: (2000)

Glycogen Synthase Kinase-3β: A Mediator of Inflammation in Alzheimer's Disease?
por: Koistinaho, Jari, et al.
Publicado: (2011)

Allosteric Regulation of Glycogen Synthase Kinase 3β: A Theoretical Study
por: Buch, Idit, et al.
Publicado: (2010)

Glycogen synthase kinase 3β represses MYOGENIN function in alveolar rhabdomyosarcoma
por: Dionyssiou, M G, et al.
Publicado: (2014)

In vivo regulation of glycogen synthase kinase 3β activity in neurons and brains
por: Krishnankutty, Ambika, et al.
Publicado: (2017)

Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma
por: Bharathy, Narendra, et al.
Publicado: (2017)

Glycogen Synthase Kinase 3β: A True Foe in Pancreatic Cancer
por: Elmadbouh, Omer H. M., et al.
Publicado: (2022)

Valproate Inhibits Methamphetamine Induced Hyperactivity via Glycogen Synthase Kinase 3β Signaling in the Nucleus Accumbens Core
por: Xing, Bo, et al.
Publicado: (2015)

PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease
por: Guardigni, Melissa, et al.
Publicado: (2023)

Glycogen Synthase Kinase-3β, NF-κB Signaling, and Tumorigenesis of Human Osteosarcoma
por: Tang, Qing-Lian, et al.
Publicado: (2012)

Expression of Glycogen synthase kinase 3-β (GSK3-β) gene in azoospermic men
por: Nazarian, Hamid, et al.
Publicado: (2014)

In Silico Approaches to Developing Novel Glycogen Synthase Kinase 3β (GSK-3β)
por: Goyal, Shuchi, et al.
Publicado: (2023)

Inhibition of Glycogen Synthase Kinase 3 (GSK3) Increases the Cytotoxicity of Enzastaurin
por: Rovedo, Mark, et al.
Publicado: (2011)

Pharmacological Inhibition of Glycogen Synthase Kinase 3 Regulates T Cell Development In Vitro
por: Schroeder, Jan-Hendrik, et al.
Publicado: (2013)

Inhibition of glycogen synthase kinase 3 by lithium, a mechanism in search of specificity
por: Chatterjee, Dipashree, et al.
Publicado: (2022)

Inhibition of glycogen synthase kinase-3β enhances cognitive recovery after stroke: the role of TAK1
por: Venna, Venugopal Reddy, et al.
Publicado: (2015)

Inhibition of Glycogen Synthase Kinase 3β Activity in the Basolateral Amygdala Disrupts Reconsolidation and Attenuates Heroin Relapse
por: Xie, Yuanyang, et al.
Publicado: (2022)

Glycogen synthase kinase 3-β inhibition induces lymphangiogenesis through β-catenin-dependent and mTOR-independent pathways
por: Stump, Benjamin, et al.
Publicado: (2019)

Glycogen Synthase Kinase-3: A Promising Therapeutic Target for Fragile X Syndrome
por: Mines, Marjelo A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_04c93of8tm6ovpt2m7gbml0pgu